New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World
... Mass., July 14 /PRNewswire/ -- The Huffington
post -- 'The Internet Newspaper' -- featured today ... to understanding the universe. The Huffington
post is ranked the most powerful (and most widely ... link to read more:
Link to Featured
post "Biocentrism, the new face of the cosmos."
...
Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice
... these kidneys may not work as well immediately
post transplantation and as a result may not last as ... as the need for dialysis in the first week
post transplantation. Evidence suggests that organs ... to those cold stored in the first two weeks
post transplantation (P=0.01).
There were no ...
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO
...
Ask Dr. Tony Milici a question,
post a comment on his profile page, and
join his ...
.
Ask Howard Leonhardt a question,
post a comment on his profile page,
and join his ... .
Ask Bill Hogan a question,
post a comment on his profile page, and join
his ...
Kingfisher Healthcare Launches Breakthrough Product in Europe
... 1st clinical trial showed excellent results in
post polio patients,
and KFH has decided to support ... the creation of an
annual Marianne Liefers
post polio Research Award, to the value of
CAD$5.000. ... conditions, including chronic fatigue in
post polio syndrome,
fibromyalgia, multiple sclerosis ...
Kansas Delegation Defends NBAF, Refutes Washington Post
... upcoming NBAF facility in Manhattan, Kansas, and responded to a Washington
post story today that was factually incorrect.
... upcoming NBAF facility in Manhattan, Kansas, and responded to a Washington
post story today that was factually incorrect. The delegation released the ...
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
... American Heart Association and the World Heart Federation Task Force. This
post hoc analysis was published in Circulation online on May 18, 2009.(2)
In this
post hoc analysis, the incidence of non-procedural heart attack in patients ...
goBalto Partners with Maya Clinicals to Expand Its List of Investigator Sites
... terms and quality. The goBalto platform allows users to rate companies,
post comments to vendors and evaluate service providers
About goBalto ... their offerings by adding logos, images, videos, customer testimonials and
post referrals from members. More than 7,000 service providers are currently ...
Baseline Research Indicates High Interest in Centocor-Ortho Biotech's SIMPONI(R)
... that will track uptake of the drug from FDA approval through six months
post launch. The research is based on results of a survey of 77 ... capturing launch effectiveness at one month, three months, and six months
post launch. The reports are designed to assess trial and use of SIMPONI (R) ...
PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
... antigen (rPA) anthrax vaccine that is being developed for pre and
post exposure protection against anthrax infection.
SparVax(TM) Phase ... recombinant protective (rPA) anthrax vaccine being developed for pre and
post exposure protection against anthrax infection. SparVax(TM) is a highly ...
Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team
... Proteolix, Inc. today announced the appointment of Craig C. Parker to the
post of Senior Vice President, Finance and Corporate Development and Chief ... team with the appointment of Michael G. Kauffman, M.D., Ph.D., to the
post of Chief Medical Officer (CMO) and Albert L. Kraus, Ph.D., to the ...
Otonomy Introduces Scientific Advisory Board
... Amicitiae Sacrum.
Christopher Post, M.D., Ph.D.
Dr.
post is the director of Allegheny Pediatric ENT Associates at Allegheny General ... from the Graduate School of Public Health, University of Pittsburgh . Dr.
post is the recipient of the Fowler Award from the Triological Society, Best ...
Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009
... (International)
Call-back numbers for
post listening:
1-800-405-2236 (US Participants)
... http://www.CellTherapeutics.com
Archived for
post viewing approximately 2 hours after the meeting ends
Media ...
PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
... antigen (rPA) anthrax vaccine that is being developed for pre and
post exposure protection against anthrax infection. Valortim(R), in ... recombinant protective (rPA) anthrax vaccine being developed for pre and
post exposure protection against anthrax infection. SparVax(TM) is a highly ...
Helping Young Women Succeed in Today's Unpredictable World
... Because the unexpected happens, www.WhatWillYourPlanBe.com offers
post college-aged women expert guidance in career, financial planning and ... financial security."
Handling Unexpected Health Issues
Because
post college-aged women have the highest rates of unintended pregnancy(2), Dr. ...
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
... Acute Care $272.5 $(0.2) $272.3 $250.6 8.7%
post Acute Care 50.3 - 50.3 38.8 29.6% ... Acute Care $934.7 $(4.8) $929.9 $883.2 5.3%
post Acute Care 197.0 - 197.0 172.9 13.9% ...
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: IMMU, KYUS
... .
Ask Cynthia Sullivan a question,
post a comment on her profile page, and
join her financial social network today ... .
Ask Steve Eversole a question,
post a comment on his profile page, and join
his financial social network today ...
Amoena Helps Women Re-shape Their Lives After Breast Cancer Surgery
... manager for Amoena ( http://www.us.amoena.com
), the worldwide leader of
post breast cancer surgery products. "Their
decisions should not be ... on their choices and stages of
healing, women's paths may include:
--
post operative products designed to work with healing -- Partial forms after ...
BayBio and BioSpace Launch Online Career Network
... pharmaceutical
and medical device employers and recruiters the ability to
post online
employment opportunities. Employers also have access to an online ... in the
Northern California life science industry can apply for jobs and
post their
resumes for viewing by local employers.
"The collaboration between ...
Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
... 1-303-262-2137 (International)
Call-back numbers for
post listening: 1-800-405-2236 (US Participants) ... at http://www.CellTherapeutics.com Archived for
post viewing approximately 2 hours after the meeting ends
Media Contact: ...
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING
... April 13, 2008, 8:00 am
to 12:00 pm. (Abstract #211, Poster Section: 8,
post Board Number: 6,
Exhibit Hall B-F, Session: Phase 1 Clinical Trials and ... 14, 2008 from 1:00 pm to 5:00 pm.
(Abstract # 3223, Poster Section: 28,
post Board Number: 26, Exhibit Hall
B-F, Session: Drug Resistance 3: Cell ...
Shire plc: IFRS Results for the Year Ending December 31, 2007
... Annual
Report on Form 10-K for the year to December 31, 2007.
Share of
post tax profit from associates and joint ventures
The Group's share of ... net 1.9 9.4 Share of
post tax profit from associates and joint ventures ...
Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
... mice models reached approximately 250 cubic
millimeters in size (day 22
post inoculation). Administration of ANAVEX
7-1037 was stopped when tumors of the control group had grown to
approximately 1,000 cubic millimeters (day 33
post inoculation).
Dacarbazine was used as a control drug and was ...
Millennium Over-Delivers on 2007 Goals and Financial Guidance
... prior to SCT. The VELCADE based induction regimen enhanced
post SCT outcomes for patients by achieving a significantly higher ... for TD. Once again, the VELCADE based induction regimen enhanced
post SCT outcomes for patients by achieving a significantly higher ...
IFRS Information - First Half of 2007
... 2007,
but this trial date has since been postponed to May 2008. Share of
post tax profits from associates and joint ventures Profits of $1.2 million ... / (expense) 2.3 (0.8) Share of
post tax profits from associates and joint ventures ...
The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.
... and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including
post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological ...
Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
... podium presentation at the American Association of Gynecologic Laparoscopists (AAGL) annual meeting in the fall of 2008 confirming that there were no
post operative issues or complications from the use of Quill SRS in a patient series that had grown to 150 patients reviewed to that date. "Bidirectional ...
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
... with only 5 patient (8%) deaths in the orBec(R) group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139). At one year
post randomization in the Phase 3 trial, 18 patients (29%) in the orBec(R) group and 28 patients (42%) in the placebo group died within one year of ...
Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia
... treatment of inhalation anthrax post-exposure. The FDA has designated Restanza as an orphan drug for the prophylactic treatment of inhalation anthrax
post exposure, but the drug is not yet approved for this or any other indication.
About Community Acquired Pneumonia (CAP)
CAP is the sixth ...
"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila
... Understanding specific market needs and backing it up with
customer centric approach will form the core of our strategy." The group
plans to
post sales of Yen 20 billion in Japan by 2015. ...
Sanofi-aventis Announces Second Quarter 2009 Results
... and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including
post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological ...
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
... dose escalation study to assess the safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients
post myocardial infarction(s).
MyoCell SDF-1 is a composition of myogenic stem cells derived from a patient's own thigh muscle that has been ...
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
... S S PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) , announced today that its European partner, SpePharm , is collecting data from a
post approval study of MuGard in head and neck cancer patients undergoing radiation treatment in the UK showing prevention of oral mucositis. In a ...
Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners
... the PPS website ( www.pricingsociety.com ) is a central resource for state-of-the-art pricing knowledge and hosts a job site where professionals can
post or review new opportunities in the industry.
About Vistaar Technologies
Vistaar is a leading provider of pricing software for sales, marketing ...
Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
... members of Wyeth's senior management team will assume significant leadership roles in R&D and commercial operations in the combined organization
post closing."
At the closing of the transaction, Wyeth stockholders will be entitled to receive $33 in cash and 0.985 of a share of Pfizer ...
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
... characterization, toxicological, and electrophysiological response experiments. The agreement also includes an ongoing cardiomyocyte supply contract
post collaboration.
Embarked upon originally in March 2008 as a validation of CDI's human pluripotent stem cell technology, the expanded agreement is ...
MEDS World, LLC Provides Multiple Environments with Designed Solutions - Wherever People Congregate, MEDS Odor Elimination Solutions Offer Eco-Friendly, Odor-Free Air
... The active-oxidant in MEDS is similar to the anti-microbial used to eliminate Anthrax spores in the Hart Senate Building in 2001 and the U.S.
post Office in Boca Raton, Florida.
http://www.epa.gov/pesticides/factsheets/chemicals/chlorinedioxidefactsheet.htm
MEDS deodorization ...
TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
... their nominations. Mr. Genachowski has been nominated by President Obama for Chairman of the Commission and Mr. McDowell is being re-nominated for a
post at the FCC he has held since 2006.
"TechNet strongly supports the nominations of Julius Genachowski and Robert McDowell for key positions on the ...
MedNet Solutions to Introduce New EDC/eClinical Technologies at the 2009 Drug Information Association Annual Meeting
... from leading sponsor and CRO organizations will be able to see firsthand how MedNet can dramatically streamline their upcoming clinical trials and
post market registries."
MedNet will be demonstrating its complete lineup of eClinical technologies in its booth (#431) in the exhibits area at the ...
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
... from those described in the forward-looking statements. The risks and uncertainties include the need to satisfy the judgment in the Parallax case or
post an appeal bond and the resulting effect on our liquidity, our limited capital resources and limited access to financing, the need to defend other ...
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
... (defined by an improvement in SELENA SLEDAI score of 4 points or greater, no BILAG worsening, and no worsening in Physician's Global Assessment;
post hoc; intention-to-treat analysis).
A decrease from 62% to 16% in the overall frequency of SLE disease flares, and from 8% to 1% in the ...